Skip Menuenglish.prescrire.org > Dossiers > Prescrire Awards > The 2010 Prescrire Awards > 2010 Prescrire Drug Awards

Dossiers > Theme: Prescrire Awards

The 2010 Prescrire Awards

The 2010 Prescrire Drug Awards


Products evaluated during the previous year in the New Products section of our French edition are eligible for the Prescrire Awards for new drugs and indications (in 2010: issues 315 to 326).

> Click here for an explanation of Prescrire's drug rating system.

> Click here for the rules governing the Awards (in French)

PILULE D'OR / "GOLDEN PILL"
The “Golden Pill” award is granted to drugs that provide a major therapeutic advance in a field in which no effective treatment was previously available.
NOT ATTRIBUTED in 2010
 
HONOURS LIST
Drugs included on the Honours List provide a clear advantage for some patients in comparison to existing therapeutic options, albeit with certain limitations.
imatinib GLIVEC°
Novartis Pharma
 inoperable or metastatic gastrointestinal stromal tumours (a second look) (Prescrire Int n° 114)
 
NOTEWORTHY
The following drugs (in alphabetical order of their international nonproprietary names – the INN is a drug’s “real name”) made a modest improvement in patient care:
azacitidine VIDAZA°
Celgene		 poor-prognosis myelodysplastic syndromes and related disorders in adults not qualifying for haematopoietic stem cell allografting
(Prescrire Int n° 113)
Japanese encephalitis vaccine
 IXIARO°
Novartis Vaccines and Diagnostics
 active immunisation of some adult travellers against Japanese encephalitis (Prescrire Int n° 106)


©Prescrire March 2011

"The 2010 Prescrire Awards"  Prescrire Int 2011; 20 (114) : 79-82. (Pdf, free)